Sunscreens prevent sunburn. They have also been proven to be somewhat effective in preventing squamous cell carcinoma (1). However, both the most numerous (basal cell carcinoma) and the most deadly (melanoma) skin cancers have little evidence for efficacy of sunscreens. Therefore, using sunscreens as an approach to skin cancer prevention for basal cell carcinoma or cutaneous malignant melanoma (CMM) at this point in time is unsupported. The epidemiologic evidence for the utility of sunscreens in preventing basal cell carcinoma or CMM is flawed by poor reliability, potential negative confounding, inadequate latency between sunscreen use and development of basal cell carcinoma or CMM, and inaccurate measurement of sunscreen application.

Suggestions have been made that sunscreens actually increase risk for skin cancer (2), although the most likely way that this association might occur is when individuals use sunscreens to prolong their stay in the sun (3-7), and so it is possible that the use of sunscreens for intentional sun exposure may actually increase risk.

Evaluation of sunscreen use is closely linked to reported sunburn history. Measurement error is a more serious problem in evaluating sunburn history than other sun-associated variables (8-10). Test-retest reliability studies have shown that sunburn history is poorly recalled with only a little over half the subjects giving the same answer at two points in time to the question: “Have you ever been sunburned severely enough to cause pain or blisters for two days or more?” Other sun-associated variables, such as time spent outdoors during recreation, for example, seem to be more reliably remembered (9).

The relationship between sun exposure, sunscreen use, and the development of skin cancer is often negatively confounded. Subjects who are extremely sun sensitive often engage in fewer activities in the bright sun and wear sunscreen when they do. As these subjects are susceptible to the development of skin cancer, they may develop skin cancer regardless of the amount of sunlight exposure or the sun protection factor of the sunscreen.

Latency between initiation and the development of melanoma is generally thought to be >10 years and likely to be as long as 40 years. All the studies reported to date have examined subjects diagnosed between 1979 and 1998 (11), none of whom would have rigorously used sunscreens 20 years before diagnosis as they were not marketed widely.

If sunscreens were to be a safe and reliable method to prevent all skin cancers, then one might expect to find a stronger relationship between sun exposure and the development of melanoma than is currently seen. Analytic epidemiologic studies have shown only modest risks for the role of sun exposure in the development of melanoma incidence; three meta-analyses show almost the same estimates of effect for the role of intermittent sun exposure, an odds ratio of 1.6 (14-16). Importantly, chronic sun exposure, as in those occupationally exposed to sunlight, does not seem to increase risk for the development of melanoma and is sometimes associated with a protective effect, with an odds ratio of 0.70, equivocal for the development of basal cell carcinoma, and a clear risk factor for squamous cell carcinoma (12). Public health campaigns that advise those with outdoor occupations to use sunscreen on a regular basis to prevent skin cancer are undoubtedly misguided, as these individuals do not seem to be at increased risk for melanoma.

Sunscreen use has not thus far been clearly associated with CMM, either positively or negatively. Eighteen published studies were pooled using standard meta-analytic techniques to examine the relationship between sunscreen use and melanoma (13). No association was seen between melanoma and sunscreen use, in either direction. These studies suffer from several limitations, the most serious of which are noted above (reliability of measure, potential uncontrollable negative confounding, latency period for the development of melanoma, and inaccurate measurement of sunscreen application).

Nevi, multiple and/or atypical, have been considered a surrogate marker for the development of melanoma. Randomized trials of sunscreen application or other sun protection have had inconsistent results about the role of sunscreen in preventing nevus formation. A small study of 309 children by Gallagher et al. (17) in Western Canada found a very small preventive effect for sunscreen; children in the sunscreen group developed fewer nevi than children in the control group, 24 versus 28. In a further analysis of these data, Lee et al. (18) reported that this effect was found mainly on the trunk, three versus five nevi, respectively. Another larger randomized trial of 970 children in Western Australia (19) found that sunscreen was not associated with the number of nevi on children's backs but that wearing clothing was protective. Several other cross-sectional studies have shown protective effects of clothing (e.g., refs. 20, 21) and a few have shown protective effects of sunscreen (e.g., ref. 22).

These conflicting and sometimes null results are consistent with the idea that sunburn, which sunscreen prevents, is only a marker of the interaction between exposure and susceptibility and that elimination of sunburn will have little effect on the development of CMM. Furthermore, it is consistent with an alternative mechanism for the development of CMM. Recent efforts to evaluate the pathways to the development of melanoma include targeting the melanocortin 1 receptor and stimulating DNA repair capacity (23). It is important to realize that the field of skin cancer prevention is still in its infancy and that it is highly complex (24). Until the mechanisms for initiation and promotion for skin cancer are clearly elucidated, it would be well to take great care in the claims for either prevention of all skin cancer by sunscreens or promotion of any skin cancer by sunscreens. Blanket advice to the public to wear sunscreens at any time outdoors is not at this time warranted. Instead, advice should focus on individual risk characteristics that are unequivocal, such as pigmentary phenotype, family history, and nevus type and number, and recommend avoidance of sun exposure by those who are clearly at high risk and reasonable enjoyment of outdoor activities with less anxiety by those who are clearly at reduced risk.

1
Green A, Williams G, Neale R, et al. Daily sunscreen application and β carotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: a randomised controlled trial.
Lancet
1999
;
354
:
723
–9.
2
Garland CF, Garland FC, Gorham ED. Could sunscreens increase melanoma risk?
Am J Public Health
1992
;
82
:
614
–5.
3
Autier P, Boniol M, Dore JF. Sunscreen use and increased duration of intentional sun exposure: still a burning issue.
Int J Cancer
2007
;
121
:
2755
–9.
4
Autier P, Dore JF, Schifflers E, et al. Melanoma and use of sunscreens: an EORTC case-control study in Germany, Belgium and France. The EORTC Melanoma Cooperative Group.
Int J Cancer
1995
;
61
:
749
–55.
5
Autier P, Dore JF, Reis AC, et al. Sunscreen use and intentional exposure to ultraviolet A and B radiation: a double blind randomized trial using personal dosimeters.
Br J Cancer
2000
;
83
:
1243
–8.
6
Autier P, Dore JF, Negrier S, et al. Sunscreen use and duration of sun exposure: a double-blind, randomized trial.
J Natl Cancer Inst
1999
;
91
:
1304
–9.
7
Thieden E, Philipsen PA, Sandby-Moller J, Wulf HC. Sunscreen use related to UV exposure, age, sex, and occupation based on personal dosimeter readings and sun-exposure behavior diaries.
Arch Dermatol
2005
;
141
:
967
–73.
8
Berwick M, Chen Y-t. Reliability of reporting sunburn history in a case-control study of cutaneous malignant melanoma.
Am J Epidemiol
1995
;
141
:
1033
–7.
9
English DR, Armstrong BK, Kricker A. Reproducibility of measures of sun exposure.
Cancer Epidemiol Biomarkers Prev
1998
;
7
:
857
–63.
10
Westerdahl JJ, Anderson H, Olsson H, Ingvar C. Reproducibility of a self-administered questionnaire for assessment of melanoma risk.
Int J Epidemiol
1996
;
25
:
245
–51.
11
Rosso S, Zanetti R, Martinez C, et al. The multicentre south European study ‘Helios’ II: different sun exposure patterns in the aetiology of basal cell and squamous cell carcinomas of the skin.
Br J Cancer
1996
;
73
:
1447
–54.
12
Dennis LK, Freeman LEB, VanBeek MJ. Sunscreen use and the risk for melanoma: a quantitative review.
Ann Intern Med
2003
;
139
:
966
–78.
13
Nelemans PJ, Rampen FHJ, Ruiter DJ, Verbeek ALM. An addition to the controversy on sunlight exposure and melanoma risk: a meta-analytical approach.
J Clin Epidemiol
1995
;
58
:
1331
–42.
14
Elwood JM, Jopson J. Melanoma and sun exposure: an overview of published studies.
Int J Cancer
1997
;
73
:
198
–203.
15
Gandini S, Sera F, Cattaruzza MS, et al. Meta-analysis of risk factors for cutaneous melanoma. II. Sun exposure [review].
Eur J Cancer
2005
;
41
:
45
–60.
16
Gallagher RP, Rivers JK, Lee TK, Bajdik CD, McLean DI, Coldman AJ. Broad-spectrum sunscreen use and the development of new nevi in white children: a randomized controlled trial.
JAMA
2000
;
283
:
2955
–60.
17
Lee TK, Rivers JK, Gallagher RP. Site-specific protective effect of broad-spectrum sunscreen on nevus development among white schoolchildren in a randomized trial.
J Am Acad Dermatol
2005
;
52
:
786
–92.
18
English DR, Milne E, Simpson JA. Sun protection and the development of melanocytic nevi in children.
Cancer Epidemiol Biomarkers Prev
2005
;
14
:
2873
–6.
19
Autier P, Dore JF, Cattaruzza MS, et al. Sunscreen use, wearing clothes, and number of nevi in 6- to 7-year-old European children. European Organization for Research and Treatment of Cancer Melanoma Cooperative Group.
J Natl Cancer Inst
1998
;
90
:
1873
–80.
20
Severi G, Cattaruzza MS, Baglietto L, et al.; European Organization for Research Treatment of Cancer (EORTC) Melanoma Cooperative Group. Sun exposure and sun protection in young European children: an EORTC multicentric study.
Eur J Cancer
2002
;
38
:
820
–6.
21
Harrison SL, Buettner PG, MacLennan R. The North Queensland “Sun-Safe Clothing” design and baseline results of a randomized trial to determine the effectiveness of sun-protective clothing in preventing melanocytic nevi.
Am J Epidemiol
2005
;
161
:
536
–45.
22
Wickelgren I. A healthy tan?
Science
2007
;
315
:
1214
–6.
23
Hill D. Skin cancer prevention: a commentary.
Am J Prev Med
2004
;
27
:
482
–3.